Penile Pain Medications
For penile pain, start with acetaminophen or NSAIDs as first-line therapy, then escalate to gabapentinoids (gabapentin 300 mg nightly, titrating to 900-3600 mg daily in divided doses) or tricyclic antidepressants (nortriptyline 10-25 mg nightly, increasing to 50-150 mg) for neuropathic components, while avoiding opioids except in acute, severe cases under specialist supervision. 1, 2
Algorithmic Approach to Penile Pain Management
First-Line: Non-Opioid Analgesics
- Acetaminophen: Up to 4 g/day in divided doses (monitor for hepatotoxicity at higher doses) 2
- NSAIDs: Ibuprofen or celecoxib for inflammatory pain components 2
Second-Line: Neuropathic Pain Agents
Gabapentinoids (preferred for neuropathic pain):
Gabapentin: Start 100-300 mg at bedtime, increase to 900-3600 mg daily in 2-3 divided doses 4, 1
- Increase by 50%-100% every few days
- Adjust for renal insufficiency
- Side effects: somnolence, dizziness, weight gain 5
Pregabalin: Start 50 mg three times daily, increase to 100 mg three times daily (maximum 600 mg/day) 4
- More efficiently absorbed than gabapentin
- Also requires renal dose adjustment
Tricyclic Antidepressants:
- Nortriptyline or desipramine (better tolerated): 10-25 mg nightly, increase to 50-150 mg 4
- Amitriptyline: More efficacious but more anticholinergic side effects (sedation, dry mouth, urinary hesitancy) 4
SNRIs:
- Duloxetine: 30-60 mg daily, increase to 60-120 mg daily 4
- Venlafaxine: 50-75 mg daily, increase to 75-225 mg daily 4
Topical Agents (Adjunctive)
- Lidocaine 5% patches: Apply daily to painful site with minimal systemic absorption 4
- Diclofenac gel: Apply 3 times daily 4
Context-Specific Considerations
For Peyronie's Disease-Related Pain:
- Subcutaneous triamcinolone injections (50 mg, nonintralesional) have shown dramatic efficacy with mean pain reduction from 6.6 to 0.5 on analog scales, with pain-free duration averaging 23.8 months 6
- This is highly effective for severe, disabling, or chronic penile pain in this specific context
For Chronic Scrotal Content Pain (CSCP):
- Follow the same multimodal approach: acetaminophen, NSAIDs, TCAs, and gabapentinoids 1
- Consider antimicrobials only if treatment-naïve with suspected infectious component 1
For Chronic Prostatitis/Chronic Pelvic Pain Syndrome:
- Tadalafil 5 mg daily may provide additional benefit for pain reduction (51% achieved 25% score reduction vs 5% placebo) 2
- Anti-inflammatory agents as part of multimodal strategy 2
Critical Pitfalls to Avoid
Opioid Prescribing: Urologists should NOT act as primary prescribers for opioids in chronic penile pain syndromes—refer to dedicated pain specialists 2. The complexity of assessment, risk of addiction, and limited long-term efficacy make this inappropriate for urologic practice.
Monotherapy Failure: A multimodal approach combining pharmacologic agents with lifestyle modifications is essential 1, 2. Titrate only one medication at a time to assess individual efficacy.
Unrealistic Expectations: The goal is improved quality of life and function, not complete pain elimination 2. Set this expectation early.
Medication Titration Errors: Always start with the smallest available dose and titrate at frequent intervals guided by pain scores and side effects 2
Anticholinergic Burden: When using TCAs, secondary amines (nortriptyline, desipramine) are better tolerated than tertiary amines (amitriptyline, imipramine), particularly in elderly patients 4
Special Populations
Renal Impairment:
Diabetics:
- May experience worse postoperative pain (HbA1c >8 associated with 41% vs 13% significant pain) 7
- May require combination opioids and gabapentin for acute postoperative scenarios
Procedural Options for Refractory Cases
If pharmacologic management fails after optimizing multiple agents:
- Dorsal nerve block has shown success in chronic penile pain cases 8
- Spermatic cord blocks for CSCP 1
- Refer to pain specialists for advanced interventions
The evidence strongly supports starting conservatively with non-opioid analgesics and escalating systematically through neuropathic pain agents before considering interventional approaches. 1, 2 This stepwise approach minimizes adverse effects while maximizing the likelihood of adequate pain control and preserved quality of life.